Greenwich Wealth Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Greenwich Wealth Management’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,070	Closed	-$15K	–	189
2018 Q1	$15K	Sell	2,070 -933	-31%	-$6.98K	﹤0.01%	176
2017 Q4	$22K	Hold	3,003	–	–	﹤0.01%	189
2017 Q3	$25K	Hold	3,003	–	–	﹤0.01%	184
2017 Q2	$31K	Hold	3,003	–	–	0.01%	181
2017 Q1	$35K	Hold	3,003	–	–	﹤0.01%	184
2016 Q4	$38K	Hold	3,003	–	–	﹤0.01%	193
2016 Q3	$55K	Hold	3,003	–	–	0.01%	206
2016 Q2	$32K	Sell	3,003 -250	-8%	-$4.91K	0.01%	200
2016 Q1	$61K	Hold	3,253	–	–	0.02%	185
2015 Q4	$87K	Hold	3,253	–	–	0.02%	152
2015 Q3	$148K	Hold	3,253	–	–	0.04%	160
2015 Q2	$105K	Hold	3,253	–	–	0.01%	168
2015 Q1	$103K	Hold	3,253	–	–	0.01%	169
2014 Q4	$123K	Sell	3,253 -272	-8%	-$7.48K	0.01%	163
2014 Q3	$93K	Hold	3,525	–	–	0.01%	170
2014 Q2	$104K	Hold	3,525	–	–	0.01%	160
2014 Q1	$130K	Hold	3,525	–	–	0.01%	158
2013 Q4	$146K	Hold	3,525	–	–	0.01%	164
2013 Q3	$187K	Hold	3,525	–	–	0.01%	153
2013 Q2	$188K	Buy	+3,525	New	+$176K	0.01%	141

Other funds holding NAVB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Greenwich Wealth Management's NAVB Position: Q2 2018 in Review

Greenwich Wealth Management sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2018, closing a stake of 2,070 shares — an estimated $15K sold.

Greenwich Wealth Management first reported a position in NAVB in Q2 2013 and held it in 20 quarters. The position peaked at $188K in Q2 2013. 54 funds tracked by Wall St. Rank hold NAVB as of Q2 2018.

Greenwich Wealth Management reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
Greenwich Wealth Management sold 2,070 Navidea Biopharmaceuticals Inc. shares in Q2 2018, an estimated $15K.
Greenwich Wealth Management first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 20 quarters.
Greenwich Wealth Management's Navidea Biopharmaceuticals Inc. position peaked at $188K in Q2 2013.
54 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2018.

Based on Greenwich Wealth Management's 13F filing for Q2 2018, filed 25 Jul 2018.